409 related articles for article (PubMed ID: 7657740)
1. Pituitary responsiveness to gonadotrophin-releasing hormone agonist stimulation: a dose-response comparison of luteinizing hormone/follicle-stimulating hormone secretion in women with polycystic ovary syndrome and normal women.
Cheung AP; Chang RJ
Hum Reprod; 1995 May; 10(5):1054-9. PubMed ID: 7657740
[TBL] [Abstract][Full Text] [Related]
2. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
3. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
[TBL] [Abstract][Full Text] [Related]
4. Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome.
Patel K; Coffler MS; Dahan MH; Malcom PJ; Deutsch R; Chang RJ
Clin Endocrinol (Oxf); 2004 Jan; 60(1):67-74. PubMed ID: 14678290
[TBL] [Abstract][Full Text] [Related]
5. Effects of a sustained release formulation of the gonadotrophin-releasing hormone agonist histrelin on serum concentrations of gonadotrophins and oestradiol, and ovarian LH/human chorionic gonadotrophin receptor content in the rat.
Gunnet JW; Demarest KT; Hahn DW; Ericson E; McGuire JL
J Endocrinol; 1991 Nov; 131(2):211-8. PubMed ID: 1744568
[TBL] [Abstract][Full Text] [Related]
6. Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.
Cheung AP; Lu JK; Chang RJ
Hum Reprod; 1997 Jun; 12(6):1156-64. PubMed ID: 9221993
[TBL] [Abstract][Full Text] [Related]
7. Changes in gonadotrophin response to gonadotrophin releasing hormone in normal women following bilateral ovariectomy.
Alexandris E; Milingos S; Kollios G; Seferiadis K; Lolis D; Messinis IE
Clin Endocrinol (Oxf); 1997 Dec; 47(6):721-6. PubMed ID: 9497880
[TBL] [Abstract][Full Text] [Related]
8. Induction of the gonadotrophin surge-inhibiting factor by FSH and its elimination: a sex difference in the efficacy of the priming effect of gonadotrophin-releasing hormone on the rat pituitary gland.
Koppenaal DW; van Dieten JA; Tijssen AM; de Koning J
J Endocrinol; 1993 Aug; 138(2):191-201. PubMed ID: 8228727
[TBL] [Abstract][Full Text] [Related]
9. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
White D; Leigh A; Wilson C; Donaldson A; Franks S
Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565
[TBL] [Abstract][Full Text] [Related]
10. GnRH agonist administration in polycystic ovary syndrome.
Buckler HM; Phillips SE; Kovacs GT; Burger HG; Healy DL
Clin Endocrinol (Oxf); 1989 Aug; 31(2):151-65. PubMed ID: 2514053
[TBL] [Abstract][Full Text] [Related]
11. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
Lewandowski KC; Cajdler-Łuba A; Salata I; Bieńkiewicz M; Lewiński A
Endokrynol Pol; 2011; 62(2):120-8. PubMed ID: 21528473
[TBL] [Abstract][Full Text] [Related]
12. Contrasts in the gonadotropin-releasing hormone dose-response relationships for luteinizing hormone, follicle-stimulating hormone and alpha-subunit release in young versus older men: appraisal with high-specificity immunoradiometric assay and deconvolution analysis.
Zwart AD; Urban RJ; Odell WD; Veldhuis JD
Eur J Endocrinol; 1996 Oct; 135(4):399-406. PubMed ID: 8921820
[TBL] [Abstract][Full Text] [Related]
13. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
Ruchhoft EA; Elkind-Hirsch KE; Malinak R
Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
[TBL] [Abstract][Full Text] [Related]
14. Effect of gonadotrophin-releasing hormone analogue (GnRH-A) administration on serum gonadotrophin and steroid levels in patients with polycystic ovarian disease.
Mongioi A; Maugeri G; Macchi M; Calogero A; Vicari E; Coniglione F; Aliffi A; Sipione C; D'Agata R
Acta Endocrinol (Copenh); 1986 Feb; 111(2):228-34. PubMed ID: 3082098
[TBL] [Abstract][Full Text] [Related]
15. Hormonal effects of GnRH agonist in the human male: II. Testosterone enhances gonadotrophin suppression induced by GnRH agonist.
Bhasin S; Heber D; Steiner B; Peterson M; Blaisch B; Campfield LA; Swerdloff RS
Clin Endocrinol (Oxf); 1984 Feb; 20(2):119-28. PubMed ID: 6232019
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic GnRH analogue administration on gonadotrophin and alpha-subunit secretion in post-menopausal women.
Oppenheim DS; Bikkal H; Crowley WF; Klibanski A
Clin Endocrinol (Oxf); 1992 Jun; 36(6):559-64. PubMed ID: 1385024
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
[TBL] [Abstract][Full Text] [Related]
19. Role of gonadal negative feedback on the gonadotrophin responses to gonadotrophin-releasing hormone (GnRH) in ram lambs from two lines of sheep selected for their luteinizing hormone response to GnRH.
Evans NP; Land RB; McNeilly JR; Webb R
J Reprod Fertil; 1991 Nov; 93(2):549-58. PubMed ID: 1787476
[TBL] [Abstract][Full Text] [Related]
20. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions.
Pagán YL; Srouji SS; Jimenez Y; Emerson A; Gill S; Hall JE
J Clin Endocrinol Metab; 2006 Apr; 91(4):1309-16. PubMed ID: 16434454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
